Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany- A Population-Based Modelling Study

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1147
https://www.valueinhealthjournal.com/article/S1098-3015(17)31481-X/fulltext
Title : Long-Term Health Benefits of Treating Non-Valvular Atrial Fibrillation with Apixaban Versus Vitamin K Antagonists In Germany- A Population-Based Modelling Study
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31481-X&doi=10.1016/j.jval.2017.08.1147
First page : A600
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1095
Categories :
Tags :
Regions :
ViH Article Tags :